The FDA has been trying to get its regulatory head around the issue of biogeneric equivalency, but it isn't easy. |
|
The European Commission cleared the biogeneric version of the drug known as epoetin alfa, Novartis, based in Basel, Switzerland, said yesterday. |
|
In the case of inlay and onlay restorations, the biogeneric software uses the residual occlusal structure surrounding the cavity of the prepared tooth. |
|